Pelosi Wants Antibody Treatment Only For Taxpayers, ‘So Trump Doesn’t Qualify’

The truth is right in front of you

When President Trump fell ill with the COVID-19 virus, he was immediately rushed to the hospital where he received state of the art treatment, the likes of which is unavailable to most members of the American public.

This is for good reason. He is the leader of the free world and we need him healthy.

And, as a thank you for his refusal to take a salary during his entire length of presidential service, the bill for this treatment is being taken care of. Trump himself does not have to pay a dime.

There are some who are upset about this last fact, Speaker of the House Nancy Pelosi among them. She is freaking out, as usual, this time about America paying “exorbitant amounts” to treat this one man.

For reasons of her own, she doesn’t feel that this is right and wants to bring the practice to an end. Not just to an end, in fact, she wants to flip the whole thing upside down.

“The president is receiving a new and exclusive treatment through antibodies. There is great hope this method may be successful and that’s wonderful. What is not so wonderful is that Donald Trump is receiving it.

Antibody treatment is pricey. Its cost is in the range of hundreds of thousands of dollars. The president is receiving this treatment gratis and that is not right.

Any treatments that are to be paid for by the American taxpayers should be reserved only for the American taxpayer… a group which Donald Trump does not belong to, as we have recently discovered.

Any man who goes to such great lengths to avoid paying into the system, should not receive the system’s benefits.

As a matter of fact, Mr. Trump’s refusal to participate as a responsible American citizen is now making me question whether he is a citizen at all. Perhaps it’s time we saw his birth certificate.”

All Americans should be outraged by Pelosi’s words. President Trump has done more in his lifetime for America than everybody else in the country combined.

Be the first to comment

Leave a Reply